Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broda 30% supramolecular salicylic acid with or without acupuncture for severe acne
ChiCTR2100042950Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Salvax in acne vulgaris (3 arms), sponsored by First Hospital of China Medical University. Primary endpoints: Global Acne Grading System score and Lesion counting. Started Feb 2021; status: recruiting.
02
Drugs
Salvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2100042950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042950.